An intranasal influenza virus-vectored vaccine prevents SARS-CoV-2 replication in respiratory tissues of mice and hamsters

Current available vaccines for COVID-19 are effective in reducing severe diseases and deaths caused by SARS-CoV-2 infection but less optimal in preventing infection. Next-generation vaccines which are able to induce mucosal immunity in the upper respiratory to prevent or reduce infections caused by...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Shaofeng, Liu, Ying, Tam, Rachel Chun-Yee, Chen, Pin, Zhang, Anna Jinxia, Mok, Bobo Wing-Yee, Long, Teng, Kukic, Anja, Zhou, Runhong, Xu, Haoran, Song, Wenjun, Chan, Jasper Fuk-Woo, To, Kelvin Kai-Wang, Chen, Zhiwei, Yuen, Kwok-Yung, Wang, Pui, Chen, Honglin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10092940/
https://www.ncbi.nlm.nih.gov/pubmed/37045873
http://dx.doi.org/10.1038/s41467-023-37697-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10092940/
https://www.ncbi.nlm.nih.gov/pubmed/37045873
http://dx.doi.org/10.1038/s41467-023-37697-1

Ejemplares similares